Smitht Alexa Kimball News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Secukinumab (Cosentyx) becomes the first IL-17A inhibitor, as well as the first drug since 2015, approved to treat adults with moderate to severe HS.

Smitht alexa kimballAlexa kimballJennifer hsiaoKunzmannk jennifer hsiaoKunzmannk matthew zirwasNovartis cosentyxMatthew zirwasHidradenitis suppurativaDrug administrationKeck school of medicineHidradenitis suppurativa clinical responseKeck schoolGreater columbusSecukinumab treatmentPublished februaryPublished june